We also evaluated S100A8 expression on double negative (DN)-2 B cells (CD19+, CD27−, CXCR5−, IgD−, CD11c+), which has recently been reported to be associated with SLE pathology [9]. This evidence concerns the gene S100A8 and systemic lupus erythematosus.